Could ditching Beta-Blockers boost heart Patients' exercise?
NCT ID NCT05019027
First seen Jun 25, 2026 · Last updated Jul 30, 2026 · Updated 3 times
Summary
This study looks at whether older adults with a heart condition called cardiac amyloidosis feel better and can exercise more when they stop taking beta-blockers. Twenty participants will each go through two periods: one on their beta-blocker and one off it. Researchers will measure exercise capacity and quality of life to see if stopping the drug makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- beta blocker
- What this could lead to
- If successful, this could show that stopping beta-blockers helps some patients with cardiac amyloidosis feel better and exercise more.
- What could go wrong
- This is a very small, early-phase study with only 20 participants. Results may not apply to everyone, and stopping beta-blockers carries risks like heart rate changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- A carpal tunnel clue to a silent heart threat?
- Heart scans may unlock hidden risks in minority communities
- Fixing sleep, fortifying hearts: a new trial tests the link
- Can a 3D virtual world rehab your heart?
- Can your genes predict blood thinner effectiveness?